LLY
ELI LILLY & CO
Health Care·Pharmaceuticals·UNITED STATES
$1,244.40
MCap $1.1T
as of 2026-08-20
Total
A2w
Fund
A2w
Quant
A9w
Price
▲ Up▼ Down━ MA30━ MA100━ Mean┄ U┄ L
MIDOS % pane · green > 90 long zone · red < 10 short zone · reference lines at 10 / 90
MIDOS SI
as of 2026-08-20
MIDOS SI
-0.09
Sentiment 64.3%
−3 oversold0+3 overbought
Signal
NEUTRAL
Actual
$1,244.40
Adaptive Mean
$1,247.52
-3.12 vs mean
Adaptive σ
18.17
MIDOS BB
$1,211.18 – $1,283.85
center ± 2σ adaptive
Fundamental Factors (Sector-Relative Z)
as of 2026-08-21
Composite Z
+0.45
ROE
102.3%
Z +2.07
Rev Gr
47.7%
Z +0.17
EPS Gr
26.2%
Z +0.29
OPM Gr
9.1%
Z +0.02
FCF Yld
1.0%
Z +0.15
EPS Surp
0.3%
Z +0.15
EPS 3mo Δ
40.6%
Z +0.26
Fwd P/E
26.38
Z —
PEGY
0.32
Cheap (GARP)
Momentum (Risk-Adjusted Alpha)
as of 2026-08-21
Q3M
14.54
Q6M
6.21
Q12M
9.09
MA 30/100
1.098
Bullish (MA30 > MA100)
α (Jensen)
0.8410
β (12M)
0.37
σ (12M)
0.358
Momentum inflection: Q3M > Q12M
Divergence — Fundamentals vs Momentum
Z Percentile
91%
Q Percentile
95%
Divergence
-3.9
Tier
ALIGNED
Fundamentals and momentum roughly in line.
Kirkpatrick RS & Persistence
RS
7.7
RS Pctl
71%
RS Decile
D8
Persistence
2w
at grade A
Options / OI Analysis
as of 2026-08-10
OI Center
$1,060.59
-12.7% from spot
Max Pain
$1,175.00
PCR (OI)
1.16
neutral
Skew
-0.35
OI Composite
-1
neutral
Direction
strong_bearish